Changes in Protein Structure May Act as Parkinson’s Biomarkers
Changes in the structure of 76 proteins in the cerebrospinal fluid (CSF) of people with Parkinson’s disease were seen when…
Articles by Patricia Inácio, PhD
Metabolon, Tracking Parkinson’s Unite to ID Disease Progression
Metabolon is teaming up with Tracking Parkinson’s, the world’s largest long-term study into Parkinson’s disease, to identify…
Novel Motor Test Added to Trial of Highland’s Brain Stimulation Device
Highland Instruments will use its new technology — called the Integrated Motion Analysis Suite or IMAS — to objectively…
ATH-1017, as Fosgonimeton, Seen to Aid Neurons and Motor Function
Early studies in nerve cells and a rat model of Parkinson’s disease support the potential of fosgonimeton, also known…
Cannabinoid Program Launches for Neurodegenerative Diseases
InMed Pharmaceuticals will launch a new program – the INM-900 series – that will investigate the therapeutic potential of…
Dosing Begins in Phase 1 Clinical Trial of AAV-GAD Gene Therapy
MeiraGTx’s new Phase 1/2 clinical trial of AAV-GAD, its investigational gene therapy for Parkinson’s disease, has…
LRRK2 Gene Variant in Parkinson’s Tied to Novel Cell Death Mechanism
A specific mutation in the LRRK2 gene — whose variants are often associated with Parkinson’s disease – renders immune…
Algorithm to ID Voice Changes May Aid in Early Detection of Parkinson’s
A new machine-learning algorithm — a type of artificial intelligence or AI — that integrates facial expression and voice recordings…
Chemical Exposure Is Key Risk Factor for Parkinson’s, Scientists Say
New scientific evidence supports a link between exposure to toxic environmental factors — pesticides, air pollutants, man-made materials, and more…
Enterin, Parkinson’s UK Planning Trial of ENT-01 in Easing Dementia
Enterin has teamed with Parkinson’s UK to launch a Phase 2 trial evaluating the ability of ENT-01, its investigational…